Here's Why Novan Inc. Is Rising Today
The announcement that an important clinical program is moving forward has put investors in a good mood.
Novan, Inc.(NOVN)
Nasdaq Capital Market (Nasdaq)
NOVN
$1.37
-$0.20
-12.7%
Price as of March 4, 2021, 9:00 p.m. EST
View Interactive NOVN Charts
Novan, Inc.
Interactive Chart
News & Analysis: Novan, Inc.
Why Novan Inc. Is Imploding Today
Shares collapsed after the company released disappointing results in one of its two phase 3 clinical trials.
Investors Wary on Noven Approval
The "tentative" status may be making investors jittery.
Monday's Worst Stocks in the World
It had to be someone.
Noven's Acquisition Blues
A recently acquired drug fails a late-stage clinical trial.
Noven's Novel Acquisition
With JDS Pharmaceuticals, the company is moving toward more traditional oral drugs.
Pay Attention to Noven
The company is smart with its money, but is relying on one drug for some time.
Noven Might Be in a Purple Patch
A new treatment for attention deficit disorder is selling so briskly, it could mean big money.
